Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Invested Capital (2016 - 2025)

Historic Invested Capital for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to $11.6 million.

  • Ekso Bionics Holdings' Invested Capital fell 2188.3% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year decrease of 2188.3%. This contributed to the annual value of $12.7 million for FY2024, which is 80.12% up from last year.
  • As of Q3 2025, Ekso Bionics Holdings' Invested Capital stood at $11.6 million, which was down 2188.3% from $10.9 million recorded in Q2 2025.
  • Over the past 5 years, Ekso Bionics Holdings' Invested Capital peaked at $41.0 million during Q1 2021, and registered a low of $10.9 million during Q2 2025.
  • Moreover, its 5-year median value for Invested Capital was $17.8 million (2023), whereas its average is $22.8 million.
  • As far as peak fluctuations go, Ekso Bionics Holdings' Invested Capital surged by 14330000.0% in 2021, and later tumbled by 5045.2% in 2023.
  • Over the past 5 years, Ekso Bionics Holdings' Invested Capital (Quarter) stood at $37.2 million in 2021, then crashed by 31.64% to $25.4 million in 2022, then tumbled by 50.45% to $12.6 million in 2023, then grew by 0.8% to $12.7 million in 2024, then dropped by 8.59% to $11.6 million in 2025.
  • Its Invested Capital was $11.6 million in Q3 2025, compared to $10.9 million in Q2 2025 and $12.7 million in Q1 2025.